Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Regado Biosciences Inc | 837,531 | reported | 03 Dec 2014 | tx 3+2,109,070 |
| Syndax Pharmaceuticals Inc | 491,690 | reported | 09 Feb 2026 | tx 109+4,124,569−1,285,854 |
| Pyxis Oncology, Inc. | 45,867 | reported | 24 Mar 2026 | tx 3+153,529 |
| RESPONSE GENETICS INC | 20,000 | reported | 30 Jul 2012 | tx 5+55,500 |
| CELL THERAPEUTICS INC | 0 | reported | 26 Jun 2023 | tx 35+819,242−819,242 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Mar 2026 | GRANT_AWARD | Pyxis Oncology, Inc. | 45,867 | 0.00 USD | deriv |
| 09 Feb 2026 | SALE | Syndax Pharmaceuticals Inc | 17,159 | 21.03 USD | |
| 04 Feb 2026 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 73,000 | 0.00 USD | |
| 06 Feb 2026 | SALE | Syndax Pharmaceuticals Inc | 7,412 | 20.62 USD | |
| 04 Feb 2026 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 144,600 | 0.00 USD | |
| 04 Feb 2026 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 440,000 | 20.43 USD | deriv |
| 08 Sept 2025 | SALE | Syndax Pharmaceuticals Inc | 157,307 | 16.41 USD | |
| 08 Sept 2025 | EXERCISE | Syndax Pharmaceuticals Inc | 157,307 | 10.90 USD | |
| 08 Sept 2025 | EXERCISE | Syndax Pharmaceuticals Inc | 157,307 | 0.00 USD | deriv |
| 16 Jul 2025 | SALE | Syndax Pharmaceuticals Inc | 7,534 | 9.29 USD | |
| 31 Mar 2025 | GRANT_AWARD | Pyxis Oncology, Inc. | 36,979 | 0.98 USD | deriv |
| 14 Mar 2025 | EXERCISE | Syndax Pharmaceuticals Inc | 6,074 | 7.20 USD | |
| 14 Mar 2025 | EXERCISE | Syndax Pharmaceuticals Inc | 6,074 | 0.00 USD | deriv |
| 04 Mar 2025 | SALE | Syndax Pharmaceuticals Inc | 7,814 | 15.05 USD | |
| 04 Mar 2025 | EXERCISE | Syndax Pharmaceuticals Inc | 7,814 | 7.20 USD | |
| 04 Mar 2025 | EXERCISE | Syndax Pharmaceuticals Inc | 7,814 | 0.00 USD | deriv |
| 10 Feb 2025 | SALE | Syndax Pharmaceuticals Inc | 13,288 | 15.50 USD | |
| 05 Feb 2025 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 89,000 | 0.00 USD | |
| 05 Feb 2025 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 60,500 | 0.00 USD | |
| 05 Feb 2025 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 364,000 | 14.65 USD | deriv |
| 10 Jun 2024 | GRANT_AWARD | Pyxis Oncology, Inc. | 70,683 | 0.00 USD | deriv |
| 07 Feb 2024 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 107,250 | 0.00 USD | |
| 07 Feb 2024 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 39,000 | 0.00 USD | |
| 07 Feb 2024 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 214,500 | 22.28 USD | deriv |
| 26 Jun 2023 | OTHER | CELL THERAPEUTICS INC | 80,000 | — | deriv |